Calleja, Jose L.

Publishing since 1993 (Senior)

Has published 42 publications in 17 years

Number of publications published per year by Calleja, Jose L.. (Source : PubMed)

Distribution of publications types for Calleja, Jose L.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Romero-Gómez M, Diago M, Andrade RJ, Calleja JL, Salmerón J, Fernández-Rodríguez CM, Solà R, García-Samaniego J, Herrerías JM, De la Mata M, Moreno-Otero R, Nuñez O, Olveira A, Durán S, Planas R. Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin. Hepatology 2009;50;6
Burgos A, Bermejo PE, Calleja JL, Vaquero A, Abreu LE. Acquired chronic hepatocerebral degeneration due to cirrhosis from non-alcoholic steatohepatitis. Rev Esp Enferm Dig 2009;101;11
Llop E, de la Revilla J, Pons F, Peñas B, Martínez JL, Abreu L, Calleja JL. Decrease in viral load at weeks 12 and 24 in patients with chronic hepatitis B treated with lamivudine or adefovir predicts virological response at week 48. Rev Esp Enferm Dig 2009;101;11
Alvarez B, Calleja JL. [Patient information. Treatment of chronic hepatitis B with oral antivirals] Rev Esp Enferm Dig 2009;101;10
Herreros de Tejada A, Calleja JL, Díaz G, Pertejo V, Espinel J, Cacho G, Jiménez J, Millán I, García F, Abreu L. Double-guidewire technique for difficult bile duct cannulation: a multicenter randomized, controlled trial. Gastrointest. Endosc. 2009;70;4
Erhardt A, Deterding K, Benhamou Y, Reiser M, Forns X, Pol S, Calleja JL, Ross S, Spangenberg HC, Garcia-Samaniego J, Fuchs M, Enríquez J, Wiegand J, Stern J, Wu K, Kukolj G, Marquis M, Beaulieu P, Nehmiz G, Steffgen J. Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment. Antivir. Ther. (Lond.) 2009;14;1
Turnes J, García-Pagán JC, González M, Aracil C, Calleja JL, Ripoll C, Abraldes JG, Bañares R, Villanueva C, Albillos A, Ayuso JR, Gilabert R, Bosch J. Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation. Clin. Gastroenterol. Hepatol. 2008;6;12
Calleja JL, Albillos A, Bañares R. [Liver diseases] Gastroenterol Hepatol 2008;31 Suppl 4
Buti M, Rodríguez Frías F, Calleja JL, Jardí R, Pons F, Crespo J, Casanovas T, Enríquez J, Carnicer F, Romero M, García Bengoechea M, Prieto M, García Samaniego J, Miras M, Pérez Roldán F, Rueda M, Esteban R. [Adefovir dipivoxil compassionate use program in Spain: efficacy and resistance analysis] Med Clin (Barc) 2007;129;15
Calleja JL, Bixquert M, Maldonado J. Impact of nocturnal heartburn on quality of life, sleep, and productivity: the SINERGE study. Dig. Dis. Sci. 2007;52;10

[ See timeline ] [ See all publications ]

h=14

means that Calleja, Jose L. has 14 papers cited a least 14 times - methodology

Key figures

42 pub in 17 years
2.5 publications/year
best year 1997 with 6 pub
h-index 14 with 42 pub
h-ratio : 33 %

See Timeline

Ranking

It's me !

Click here if you are
Calleja, Jose L..

Most frequent Journals

Gastrointest. Endosc. (6x)
Med Clin (Barc) (6x)
Hepatology (5x)
Gastroenterol Hepatol (5x)
Dig. Dis. Sci. (4x)

Main affiliation

Services of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Latest co-workers

Abreu L Albillos A Alvarez-Mon M Bañares R Benhamou Y Bosch J Cacho G Enríquez J Escartín P Espinel J Forns X García-Pagán JC González M Nehmiz G Planas R Pons F Reiser M Ruiz-del-Arbol L Steinmann GG Villanueva C

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.